Rudolf Stauber

University of Graz — Austria

Medicine · Health Sciences

63h-index18.4kcitations387works3.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(167), Liver Disease and Transplantation(106), Hepatitis C virus research(104), Hepatitis B Virus Studies(50), Hepatocellular Carcinoma Treatment and Prognosis(28)

Publications381 total

An observational study on the effect of l-ornithine-l-aspartate (LOLA) on the gut microbiome in liver cirrhosis. A single center phase 4 study
Clinical Nutrition·2025Open Access
Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
Journal for ImmunoTherapy of Cancer·2025Open Access
Exercise performance for long-term outcome prediction in patients with liver cirrhosis
2025
Real-World Analyse von Patienten mit Voxilaprevir (VOX)/Velpatasvir (VEL)/Sofosbuvir (SOF) Therapieversagen: Ergebnisse des klinischen Follow-Ups
Zeitschrift für Gastroenterologie·2025
Depletion of Small HDL Subclasses Predicts Poor Survival in Liver Cirrhosis
Antioxidants·2025Open Access
WED-083 Role of Child-Turcotte-Pugh and ALBI scores in patients with non-cirrhotic hepatocellular carcinoma
Journal of Hepatology·2025
TOP-473 Histological features predict response to corticosteroids and short-term survival in severe alcohol-associated hepatitis
Journal of Hepatology·2025
Molecular Landscape and Treatment Paradigms of Hepatocellular and Cholangiocarcinoma: A Multinational Review
Zeitschrift für Gastroenterologie·2025Open Access
Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy
Hepatology·2024· 22 cited
OS-112-YI Outcome and management of patients with hepatocellular carcinoma who achieved complete response to immunotherapybased systemic therapy
Journal of Hepatology·2024· 4 cited
SAT-042 A HDL-based prognostic model performs better than MELD in chronic liver failure
Journal of Hepatology·2024Open Access
Outcome and management of patients with hepatocellular carcinoma who achieved complete response to immunotherapy-based systemic therapy
Zeitschrift für Gastroenterologie·2024
Machine learning-based assessment of tumour-infiltrating lymphocytes predicts outcomes in patients with hepatocellular carcinoma undergoing atezolizumab and bevacizumab treatment
Zeitschrift für Gastroenterologie·2024
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients
JHEP Reports·2024· 7 citedOpen Access
Validation of NIAAAm-CRP criteria to predict alcohol-associated steatohepatitis on liver histology
JHEP Reports·2024· 3 citedOpen Access
Gender-Specific Bile Acid Profiles in Non-Alcoholic Fatty Liver Disease
Nutrients·2024· 22 citedOpen Access
Effect of albumin infusion on oxidative albumin modification and albumin binding capacity in chronic liver failure
Basic & Clinical Pharmacology & Toxicology·2023Open Access
A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma
JHEP Reports·2023· 22 citedOpen Access
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study
Hepatology Communications·2023· 10 citedOpen Access
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
The Lancet·2023· 418 citedOpen Access
page 1 of 20Next →

Frequent Co-authors

Michael Trauner(13), Vanessa Stadlbauer(12), Péter Ferenci(10), A Maieron(10), Christian Datz(10), Joan Clària(9), Richard Moreau(9), Marco Pavesi(9), Carlo Alessandria(9), Jonel Trebicka(9), Vicente Arroyo(9), Michael Gschwantler(9), Karl Oettl(8), Alexander L. Gerbes(8), Thierry Gustot(8), Àlex Amorós(7), Wim Laleman(7), Faouzi Saliba(7), Agustı́n Albillos(7), Pere Ginès(7)